Article
A high-resolution genomic and phenotypic analysis of resistance evolution of an<i>Escherichia coli</i>strain from a critical care patient treated with piperacillin/tazobactam
2024-01-16
Abstract excerpt
Resistance to the β-lactam/β-lactamase inhibitor (BL/BLI) combination antibiotic piperacillin/tazobactam (TZP) predominantly occurs via β-lactamase enzymes also leading to resistance to third-generation cephalosporins (3GCs). However, if β-lactamases inactive against 3GCs and inhibited by tazobactam are expressed at high levels leading to enzyme hyperproduction, the surplus enzyme escapes inhibition by tazobactam...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2209c9e4-b13d-53fd-9692-4f628e3d890f
- DOI
- 10.1101/2024.01.15.24301199
